Evidence map›Paper›PMID 41854717›Full record

ArticleZeitschrift fur Rheumatologie2026

[Proposal of the rheumatology societies in the D-A-CH region for a uniform German nomenclature for Sjögren's disease].

Diana Ernst, die Deutsche Gesellschaft für Rheumatologie und klinische Immunologie e. V. (DGRh), Thomas Dörner, Martin Aringer, Stephanie Finzel, Lisa Christ, die Schweizerische Gesellschaft für Rheumatologie (SGR), Diana Dan, Alexandre Dumusc, Isabell Haase and 14 more

Erratum issuedAbstract readConsensus StatementEnglish Abstract
PubMed Full text at PMC Publisher
In one paragraph

Article in Zeitschrift fur Rheumatologie, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

  • Erratum issued
    2026
5 · Who and what money

Authors and funding

24 authors.

Diana ErnstMedizinische Hochschule Hannover, Hannover, Deutschland.
die Deutsche Gesellschaft für Rheumatologie und klinische Immunologie e. V. (DGRh)
Thomas DörnerCharité Universitätsmedizin Berlin Campus Charite Mitte: Charité Universitätsmedizin Berlin, Berlin, Deutschland.
Martin AringerUniversitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden, Dresden, Deutschland.
Stephanie FinzelUniversitätsklinikum Freiburg, Freiburg, Deutschland.
Lisa ChristUniversitätsklinik für Rheumatologie und Immunologie, Inselspital, Universitätsspital Bern, Universität Bern, Bern, Schweiz.
die Schweizerische Gesellschaft für Rheumatologie (SGR)
Diana DanService de rhumatologie, Centre Hospitalier Universitaire Vaudois, Lausanne, Schweiz.
Alexandre DumuscService de rhumatologie, Centre Hospitalier Universitaire Vaudois, Lausanne, Schweiz.
Isabell HaaseUniversitätsklinikum Hamburg Eppendorf, III. Medizin, Sektion für Rheumatologie und Entzündliche Systemerkrankungen, Hamburg, Deutschland.
Ina KötterUniversitätsklinikum Hamburg Eppendorf, III. Medizin, Sektion für Rheumatologie und Entzündliche Systemerkrankungen, Hamburg, Deutschland.
Anna MeineckeMedizinische Hochschule Hannover, Hannover, Deutschland.
Ulf Müller-LadnerJustus-Liebig Universität Giessen, Abt. Rheumatologie und Klinische Immunologie, Campus Kerckhoff, Bad Nauheim, Deutschland.
Gabriela RiemekastenUniversitätsklinikum Schleswig-Holstein, Campus Lübeck, Lübeck, Deutschland.
Marc SchmalzingMedizinische Klinik und Poliklinik 2, Universitätsklinik Würzburg, Würzburg, Deutschland.
Christof SpeckerEv. Kliniken Essen-Mitte, Essen, Deutschland.
Christina DuftnerUniv.-Klinik für Innere Medizin II, Medizinische Universität Innsbruck, Innsbruck, Österreich.
die Österreichische Gesellschaft für Rheumatologie und Rehabilitation (ÖGR)
Martin Helmut StradnerKlinische Abteilung für Rheumatologie und Immunologie, Medizinische Universität Graz, Graz, Österreich.
Paul StudenicUniversitätsklinik für Innere Medizin III, Medizinische Universität Wien, Wien, Österreich.
Anne-Kathrin TauscheUniversitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden, Dresden, Deutschland.
Jens ThielKlinische Abteilung für Rheumatologie und Immunologie, Medizinische Universität Graz, Graz, Österreich.
Ulf WagnerUniversitätsklinikum Leipzig, Leipzig, Deutschland.
Torsten WitteKlinik für Rheumatologie und Immunologie, Medizinische Hochschule Hannover, Carl-Neuberg-Str. 1, 30625, Hannover, Deutschland. Witte.Torsten@mh-hannover.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSjögren's syndrome is now referred to internationally as Sjögren's disease (abbreviated SjD).

objectivesThe aim was to reach a consensus on how Sjögren's syndrome should be referred to in German-speaking countries in the future. MATERIAL AND

methodsThe authors of this manuscript were appointed by the three professional associations in the D‑A-CH region, the German Society for Rheumatology and Immunology (DGRh), the Austrian Society for Rheumatology (ÖGR) and the Swiss Society for Rheumatology (SGR) to implement the international recommendations for the German-speaking region.

resultsThe term "Sjögren-Erkrankung" should replace "Sjögren-Syndrom." The English abbreviation "SjD" (Sjögren's disease) should also be used in German as an abbreviation for "Sjögren-Erkrankung." The term "associated" should be used instead of "secondary" for Sjögren's disease that occurs in conjunction with another classifiable systemic autoimmune disease.

Indexed as

RheumatologySjogren's SyndromeSocieties, MedicalTerminology as TopicGermanyHumansConsensusPrimary Sjögren`s syndromeSjDSjögren’s diseaseSjögren’s syndrome

Identifiers

PMID41854717
PMCPMC13558428

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.